Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 04, 2026 08:05 ET | Source: AKD

AKD Signs Exclusive License to Bring Binaxity's Asset-Backed Lending Platform to US Institutions

RENO, Nev., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Agreement authorizes AKD to offer best-in-class Bitcoin-backed lending and non-margin gold and Bitcoin accumulation products to...
September 03, 2026 16:45 ET | Source: Rogers Communications Canada Inc.

Rogers and Quebecor Agree to New 12-Year Sublicensing Deal for National NHL Games in French

TVA Sports to broadcast up to 350 regular-season NHL games Montréal Canadiens: 32 regular-season games and exclusive rights to Stanley Cup Playoffs games in French TORONTO, Sept. 03, 2026 (GLOBE...
September 03, 2026 16:45 ET | Source: Rogers Communications Canada Inc.

Rogers et Québecor concluent une nouvelle entente de sous-licence de 12 ans visant les droits nationaux de diffusion des matchs de la LNH en français

TVA Sports diffusera jusqu'à 350 matchs en saison régulière de la LNH Canadiens de Montréal : 32 matchs en saison régulière et exclusivité des matchs lors des séries éliminatoires de la Coupe Stanley...
September 03, 2026 16:08 ET | Source: NorthStrive Companies Inc.

NorthStrive® Companies Inc. Announces New Brand Identity and Establishes Trademark Licensing Strategy

NEWPORT BEACH, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- NorthStrive® Companies Inc. (“NorthStrive Companies”), a privately held management, investment, and advisory firm, today announced the...
September 03, 2026 00:00 ET | Source: HUTCHMED (China) Limited

HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy

— Exclusive License for HMPL-A830, a first-in-class KRAS-EGFR Antibody-Targeted Therapy Conjugate (“ATTC”), which is expected to enter clinical trials in H2 2026 —— HUTCHMED webcasts today at...
August 31, 2026 07:00 ET | Source: Ascendis Pharma

Ascendis and BioMarin Enter Binding Term Sheet for a Global Settlement and License Agreement Related to YUVIWEL® (Navepegritide)

COPENHAGEN, Denmark, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it has entered into a binding term sheet for a global settlement and license agreement with...
August 30, 2026 22:00 ET | Source: Leios Therapeutics

Leios Therapeutics Announces Exclusive Licensing Agreement and Strategic Investment with Subsidiaries of China Medical System Holdings Ltd. for 10XB-101

10XB-101 is a Novel Potential Best-in-Class Injectable Drug Being Developed for Focal Fat Reduction and Body Contouring Second Major Regional Licensing and Strategic Investment Agreement in 2026;...
August 28, 2026 07:00 ET | Source: Octopus AIM VCT PLC

Issue of Equity and Total Voting Rights

OCTOPUS AIM VCT PLC Issue of Equity and Total Voting Rights Octopus AIM VCT plc (the ‘Company’) announces the allotment and issue of 2,609,154 Ordinary shares of 1p each at a price of 39.8p per...
August 26, 2026 09:00 ET | Source: Upper Deck

Upper Deck Announces New Licensing Agreement with Hasbro

Upper Deck announces new licensing deal with Hasbro, bringing Transformers, Power Rangers, G.I. Joe, M.A.S.K., and more to trading cards and games.
August 25, 2026 09:00 ET | Source: EnWave Corporation

EnWave Announces Healthy Snack Launch of Loovies LLC, a Previously Unnamed Royalty Partner

VANCOUVER, British Columbia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announces that Loovies LLC (“Loovies”), a Mexican-based...